Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CYRX | Common Stock | Options Exercise | $203K | +14.1K | +14.13% | $14.35 | 114K | Sep 13, 2021 | Direct | |
transaction | CYRX | Common Stock | Options Exercise | $196K | +10.9K | +9.52% | $18.02 | 125K | Sep 13, 2021 | Direct | |
transaction | CYRX | Common Stock | Sale | -$232K | -3.7K | -2.96% | $62.72 | 121K | Sep 15, 2021 | Direct | F3 |
transaction | CYRX | Common Stock | Sale | -$966K | -15.1K | -12.43% | $64.08 | 106K | Sep 15, 2021 | Direct | F4 |
transaction | CYRX | Common Stock | Sale | -$402K | -6.22K | -5.86% | $64.55 | 100K | Sep 15, 2021 | Direct | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CYRX | Options to purchase common stock | Options Exercise | $0 | -14.1K | -100% | $0.00* | 0 | Sep 13, 2021 | Common Stock | 14.1K | $14.35 | Direct | F1 |
transaction | CYRX | Options to purchase common stock | Options Exercise | $0 | -10.9K | -31.05% | $0.00 | 24.1K | Sep 13, 2021 | Common Stock | 10.9K | $18.02 | Direct | F2 |
Id | Content |
---|---|
F1 | 1/12 of these options vested and became exercisable on the 1st of each month for twelve (12) months beginning on 05/02/2019. |
F2 | 1/12 of these options vested and became exercisable on the 1st of each month for twelve (12) months beginning on 06/01/2020. |
F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.38 to $63.32, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.40 to $64.39, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.40 to $64.923, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |